Arzneiwerk AG VIDA (HAM:TLIK) Cyclically Adjusted FCF per Share: €-0.29 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:TLIK Arzneiwerk AG VIDA HAM:TLIK
40 GF Score
Price €0.20
! 7 Warning Signs
View Full Analysis

What is Arzneiwerk AG VIDA Cyclically Adjusted FCF per Share?

Arzneiwerk AG VIDA HAM:TLIK 40 Cyclically Adjusted FCF per Share is €-0.29 as of Mar. 2026. GuruFocus rates HAM:TLIK with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Arzneiwerk AG VIDA's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.017. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.29 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Arzneiwerk AG VIDA was 29.50% per year. The lowest was 2.00% per year. And the median was 17.90% per year.

As of today (2026-08-31), Arzneiwerk AG VIDA's current stock price is €0.20. Arzneiwerk AG VIDA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.29. Arzneiwerk AG VIDA's Cyclically Adjusted Price-to-FCF of today is .


Arzneiwerk AG VIDA  (HAM:TLIK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Arzneiwerk AG VIDA Cyclically Adjusted FCF per Share Related Terms


Arzneiwerk AG VIDA Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Arzneiwerk AG VIDA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arzneiwerk AG VIDA Cyclically Adjusted FCF per Share Chart

Arzneiwerk AG VIDA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 0.00 -0.31 -0.38 -0.19

Arzneiwerk AG VIDA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.32 -0.28 -0.12 -0.19 -0.29

HAM:TLIK vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arzneiwerk AG VIDA Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's Cyclically Adjusted Price-to-FCF falls into.


HAM:TLIK
40GF Score
Arzneiwerk AG VIDA HAM:TLIK
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arzneiwerk AG VIDA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arzneiwerk AG VIDA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.017/131.2583*131.2583
=-0.017

Current CPI (Mar. 2026) = 131.2583.

Arzneiwerk AG VIDA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.159 100.717 -0.207
201609 -0.168 101.017 -0.218
201612 -0.118 101.217 -0.153
201703 0.022 101.417 0.028
201706 0.047 102.117 0.060
201709 -0.221 102.717 -0.282
201712 -0.043 102.617 -0.055
201803 -0.076 102.917 -0.097
201806 -0.122 104.017 -0.154
201809 0.161 104.718 0.202
201812 -0.262 104.217 -0.330
201903 -0.065 104.217 -0.082
201906 -0.020 105.718 -0.025
201909 -0.121 106.018 -0.150
201912 -0.020 105.818 -0.025
202003 -0.065 105.718 -0.081
202006 -0.143 106.618 -0.176
202009 -0.124 105.818 -0.154
202012 0.034 105.518 0.042
202103 0.011 107.518 0.013
202106 -0.035 108.486 -0.042
202109 -0.003 109.435 -0.004
202112 -0.034 110.384 -0.040
202203 0.289 113.968 0.333
202206 -0.199 115.760 -0.226
202209 -0.050 118.818 -0.055
202212 0.000 119.345 0.000
202303 0.162 122.402 0.174
202306 0.000 123.140 0.000
202309 0.253 124.195 0.267
202312 -0.626 123.773 -0.664
202403 -0.034 125.038 -0.036
202406 -0.023 125.882 -0.024
202409 -0.050 126.198 -0.052
202412 -0.029 127.041 -0.030
202503 0.002 127.779 0.002
202506 -0.030 128.412 -0.031
202509 -0.027 129.255 -0.027
202512 -0.020 129.361 -0.020
202603 -0.017 131.258 -0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.29 mean?
Arzneiwerk AG VIDA (HAM:TLIK) has a Cyclically Adjusted FCF per Share of €-0.29 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arzneiwerk AG VIDA and its competitors.
Is Arzneiwerk AG VIDA's Cyclically Adjusted FCF per Share too high?
Arzneiwerk AG VIDA's current Cyclically Adjusted FCF per Share is €-0.29. Overall, Arzneiwerk AG VIDA has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Arzneiwerk AG VIDA's Cyclically Adjusted FCF per Share compare to MCK and COR?
Arzneiwerk AG VIDA's Cyclically Adjusted FCF per Share of €-0.29 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arzneiwerk AG VIDA and its competitors. Arzneiwerk AG VIDA's current Cyclically Adjusted FCF per Share is €-0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arzneiwerk AG VIDA stock overvalued right now?
Arzneiwerk AG VIDA (HAM:TLIK) has a current Cyclically Adjusted FCF per Share of €-0.29. The current Cyclically Adjusted FCF per Share is €-0.29. Arzneiwerk AG VIDA's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Arzneiwerk AG VIDA (HAM:TLIK), the current Cyclically Adjusted FCF per Share is €-0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arzneiwerk AG VIDA Business Description

Other Exchanges TLIK:Germany
Address Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
40GF Score

Get the complete analysis for HAM:TLIK

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price